Literature DB >> 11356337

The molecular genetics of pancreatic ductal carcinoma: a review.

T A Sohn1, C J Yeo.   

Abstract

In the last several years, numerous advances in the field of molecular genetics have been applied to pancreatic ductal carcinoma- the 5th leading cause of cancer death in the United States. This review summaries the current knowledge about adenocarcinoma of the pancreas.

Entities:  

Mesh：

Year:  2000        PMID： 11356337     DOI： 10.1016/s0960-7404(00)00041-4

Source DB:  PubMed          Journal:  Surg Oncol        ISSN： 0960-7404            Impact factor:   3.279


  7 in total

1.  Screening for pancreatic cancer: current evidence and future directions.

Authors:  Julia B Greer; Randall E Brand
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-12

Review 2.  Biological approaches to therapy of pancreatic cancer.

Authors:  Han Hsi Wong; Nicholas R Lemoine
Journal:  Pancreatology       Date:  2008-08-25       Impact factor: 3.996

3.  Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.

Authors:  Charles J Yeo; John L Cameron; Keith D Lillemoe; Taylor A Sohn; Kurtis A Campbell; Patricia K Sauter; JoAnn Coleman; Ross A Abrams; Ralph H Hruban
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

4.  Incidence of pancreatic cancer in Greenland 2000-2010.

Authors:  Jakob Kirkegaard
Journal:  Int J Circumpolar Health       Date:  2012-05-22       Impact factor: 1.228

5.  G-quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcription.

Authors:  Susanna Cogoi; Luigi E Xodo
Journal:  Nucleic Acids Res       Date:  2006-05-10       Impact factor: 16.971

6.  Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer.

Authors:  E Angst; S Sibold; C Tiffon; R Weimann; B Gloor; D Candinas; D Stroka
Journal:  Br J Cancer       Date:  2006-07-11       Impact factor: 7.640

7.  Histone Deacetylase Inhibition Restores Expression of Hypoxia-Inducible Protein NDRG1 in Pancreatic Cancer.

Authors:  Céline Tiffon
Journal:  Pancreas       Date:  2018-02       Impact factor: 3.327
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.